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Mammalian sulfotransferases (STs) utilize exclusively the sulfuryl group donor 30-phosphoadeno-
sine 50-phosphosulfate (PAPS) to catalyze the sulfurylation reactions based on a sequential transfer
mechanism. In contrast, the commensal intestinal bacterial arylsulfate sulfotransferases (ASSTs) do
not use PAPS as the sulfuryl group donor, but instead catalyze sulfuryl transfer from phenolic sul-
fate to a phenol via a Ping-Pong mechanism. Interestingly, structural comparison revealed a similar
spatial arrangement of the active site residues as well as the cognate substrates in mouse ST
(mSULT1D1) and Escherichia coli CFT073 ASST, despite that their overall structures bear no discern-
ible relationship. These observations suggest that the active sites of PAPS-dependent SULT1D1 and
phenolic sulfate-utilizing ASST represent an example of convergent evolution.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Sulfotransferases (STs) are enzymes that catalyze the sulfate
conjugation of carbohydrates, proteins, and a variety of low-molec-
ular weight endogenous and exogenous compounds. Sulfate conju-
gation, also referred to as sulfurylation, sulfation, or sulfonation, is
widely utilized among both prokaryotic and eukaryotic organisms
and plays important roles in various biological/physiological pro-
cesses such as cell communication, growth and development, and
host defense [1,2]. To date, a large number of STs have been iden-
tiﬁed in mammals and characterized with regard to enzymatic
properties and protein structure [3]. STs in mammals generally uti-
lize 30-phosphoadenosine 50-phosphosulfate (PAPS) as the sulfuryl
group donor to catalyze the sulfurylation reaction, yielding 30-
phosphoadenosine 50-phosphate (PAP) and sulfurylated products.
Mammalian STs are grouped into two major classes on the basis
of their subcellular localization and physiological substrates. Cyto-
solic STs, designated as SULTs [4], sulfonate small molecules suchchemical Societies. Published by E
ctural Biology, Department of
riculture, Kyushu University,
n. Fax: +81 92 642 2854.
uta).as steroids, bioamines, and therapeutic drugs [1,5], while the Golgi
membrane-bound STs sulfonate macromolecules including glycos-
aminoglycans [6] and proteins [7]. While the overall amino acid
sequences of cytosolic and membrane-bound STs are dissimilar,
sequence alignments have revealed a number of conserved resi-
dues [8]. Moreover, crystallographic analyses showed that both
cytosolic and membrane-bound STs are single a/b globular pro-
teins with a characteristic ﬁve-stranded parallel b-sheet [3]. The
b-sheet constitutes the PAPS-binding site and the core of the cata-
lytic site, both of which are composed of conserved residues in
cytosolic as well as membrane-bound STs.
We recently determined the crystal structure of a Michaelis
complex composed of a mouse SULT1D1 (mSULT1D1) in complex
with PAPS and p-nitrophenol (pNP) at a high resolution [9]. To
our knowledge, this is the ﬁrst structure of a Michaelis complex
of the SULT family enzymes. The data on the Michaelis complex
structure strongly supports a proposed SN2-like in-line displace-
ment mechanism of the reaction catalyzed by the SULT family en-
zymes and are fully consistent with previously reported structural
and functional studies [2,3,10–14].
Apart from mammalian STs, arylsulfate sulfotransferases
(ASSTs) in commensal intestinal bacteria have been proposed to
play a role in the detoxiﬁcation of phenolic compounds [15,16].lsevier B.V. All rights reserved.
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and do not use PAPS as the sulfuryl group donor. This PAPS-inde-
pendent catalysis distinguishes bacterial ASSTs from mammalian
STs that use exclusively PAPS as the sulfuryl group donor [10].
Although a number of mammalian STs have been extensively stud-
ied, much less is known about bacterial ASSTs. A recent structural
study on the uropathogenic Escherichia coli CFT073 ASST revealedFig. 1. Structural comparison of mSULT1D1 with E. coli CFT073 ASST. (A) Overall structur
complexed with PAPS and pNP. (D) Active site structure of ASST complexed with covalen
ASST. The key residues are shown in a stick model.that this ASST homodimer comprises a 6-bladed b-propeller do-
main fused to an N-terminal b-sandwich domain that differs fun-
damentally from all other structurally characterized mammalian
STs [17]. Moreover, the structural and biochemical studies identi-
ﬁed His252, His356, Arg374, and His436 as catalytic residues and
revealed that ASST operates based on a Ping–Pong bi–bi reaction
mechanism, in which His436 undergoes transient sulfurylatione of mSULT1D1. (B) Overall structure of ASST. (C) Active site structure of mSULT1D1
tly bonded SO3 and pNP. (E) Stereo superposition of active sites of mSULT1D1 and
T. Teramoto et al. / FEBS Letters 583 (2009) 3091–3094 3093[17]. Thus, ASST reacts ﬁrst with a donor substrate and releases the
ﬁrst product before reacting with an acceptor substrate, whereas
PAPS-dependent mammalian STs catalyze direct fulruryltransfer
by binding both the sulfuryl donor PAPS and the acceptor simulta-
neously without becoming covalent modiﬁed.
Unexpectedly, superposition of the mSULT1D1 and E. coli ASST
structures, based on the accepter substrate (pNP), revealed that
the positions of the sulfuryl moiety of PAPS in mSULT1D1 and sulf-
urylated His436 in ASST were well superimposed. We hereby repot
a similar spatial arrangement of the catalytic residues and sub-
strates between the two structures, one being a PAPS-dependent
mSULT1D1 operating based on a sequential reaction mechanism
and the other being a PAPS-independent bacterial ASST operating
based on a Ping-Pong mechanism.2. Results and discussion
Fig. 1A shows the crystal structure of mSULT1D1 in complex
with PAPS and pNP. The overall structure and the spatial location
of the catalytic residues in mSULT1D1 are highly homologous to
those of other members of the SULT1 subfamily [18]. In the
Michaelis complex of mSULT1D1, Lys48 hydrogen bonds the bridg-
ing oxygen (2.8 Å) as well as one oxygen of the sulfuryl group
(3.1 Å) and His108 hydrogen bonds another oxygen of the sulfuryl
group (3.2 Å) and the hydroxyl group (2.5 Å) of pNP (Fig. 1C).
Hence, it seems probable that Lys48 serves to donate its proton
to the bridging oxygen as a catalytic acid, stabilizing the transition
state by interacting with the SO3 moiety of PAPS that is being
transferred, while His108 serves as a catalytic base that removes
a proton from the phenolic hydroxyl group of pNP and stabilizes
the transition state by interacting with the SO3 moiety of PAPS.
In addition, the side chain nitrogen of Lys106 is in a position to
form interactions with another oxygen (3.3 Å) of the SO3 moiety
and the acceptor phenolic hydroxyl group (2.9 Å) of the pNP mol-
ecule (Fig. 1C).
Surprisingly, superimposition of pNPs in the active sites of
mSULT1D1 and ASST using the program Coot [19] showed a signif-
icant structural similarity of the catalytic residues as well as SO3
moieties within the active sites of these two sulfotransferases, in
spite of that the overall folds of these two structures bear no
resemblance (Fig. 1A and B). In the ASST structure, the sulfuryl
moiety of sulfurylated-His436 is stabilized by extensive hydrogen
bonding to the side chains of His252, Asn358, Arg374, His356
and backbone nitrogen of Thr501 (Fig. 1B and D). Interestingly,
the positions of the sulfuryl moieties of PAPS in mSULT1D1 and
sulfurylated His436 residue in ASST are well superposed, being
3.1 Å in distance to the phenolic hydroxyl group of pNP (Fig. 1E).
In addition, proposed catalytic residues Lys106 and His108 in
mSULT1D1 are well superposed, respectively, with the proposed
catalytic residues His252 and His356 in ASST. Moreover, proposed
catalytic acid Lys48 in mSULT1D1 aligns well with main chain
nitrogen (Thr501) of ASST. All these catalytic residues have been
shown to be highly conserved within each of the two sulfotransfer-
ase families and mutational analyses of these residues signiﬁcant
reduced their catalytic activities [3,14].
Furthermore, it has been reported that a gate-like structure
formed by two hydrophobic residues is responsible for recognizing
the phenolic ring of the accepter substrate in the mammalian
SULT1 family [20]. In the mSULT1D1 Michaelis complex, Phe81
and Phe142 constitute a gate-like structure, forming a hydrophobic
interaction with the aromatic ring of pNP (Fig. 1C). For ASST, the
aromatic ring of pNP forms a hydrophobic contact with the resi-
dues Phe171 and Ile500 (Fig. 1D). Again, the positions of Phe81
and Phe142 in mSULT1D1 can be superimposed on those of
Phe171 and Ile500 of ASST. Hence, not only catalytic residues butalso substrate-recognizing residues in mSULT1D1 and ASST are
well superimposed (Fig. 1E).
In summary, mammalian STs exclusively utilize PAPS to cata-
lyze the sulfurylation reactions based on a sequential mechanism
(single-displacement reactions). In contrast, bacterial ASSTs cata-
lyze the sulfurylation reactions via a Ping-Pong mechanism (dou-
ble-displacement reactions). Furthermore, mammalian STs fold
into a single a/b globular protein structure with a characteristic
ﬁve-stranded parallel b-sheet, while ASST consists of an N-terminal
b-sandwich domain and a 6-bladed b-propeller domain. Neverthe-
less, the sulfuryl group being transferred and the acceptor hydroxyl
group of the phenyl ring are positioned approximately 3.1 Å apart
and similarly coordinated by catalytic residues in the two en-
zymes. Although it is premature on the basis of only one ASST
structure to draw ﬁrm conclusions, it seems probable that the
PAPS-dependent mammalian STs and the phenolic sulfate-utilizing
ASST constitute an example of convergent evolution. Further bio-
chemical and structural studies on bacterial ASSTs are warranted
in order to unequivocally answer this question.
3. Methods
The atomic coordinates and structure factors of mSULT1D1 in
complex with PAPS and pNP, and ASST in complex with pNP were
obtained from the Protein Data Bank at Rutgers University under
Accession Codes 2ZYV and 3ETS, respectively. The program Coot
[19] was used to superimpose the crystal structures.Acknowledgments
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